CISA KEV · Known exploitedHigh

CVE-2024-4978

Justice AV Solutions Viewer

Justice AV Solutions Viewer Setup 8.3.7.250-1 contains a malicious binary when executed and is signed with an unexpected authenticode signature. A remote, privileged threat actor may exploit this vulnerability to execute of unauthorized PowerShell commands.

CVSS
8.7
EPSS
26.9%
97.8% percentile
CISA KEV
Listed
Published
2024.05.23
PRIORITY ASSESSMENT

Immediate review

CISA has listed this vulnerability in the Known Exploited Vulnerabilities catalog.

Known exploitationConfirmed by CISA KEV
Exploit probability26.9%
Technical severityCVSS 8.7

Vulnerability overview

Justice AV Solutions Viewer Setup 8.3.7.250-1 contains a malicious binary when executed and is signed with an unexpected authenticode signature. A remote, privileged threat actor may exploit this vulnerability to execute of unauthorized PowerShell commands.

Affected product and versions

Product
Justice AV Solutions Viewer
Affected versions
8.3.7.250
Fixed versions
No verified fixed-version field is available yet

Recommended response sequence

Confirm exposure before applying a vendor-supported change.

Full remediation guide
CISA required action

Apply mitigations per vendor instructions or discontinue use of the product if mitigations are unavailable.

Due date: 2024.06.19
  1. 1
    Identify

    Confirm that Justice AV Solutions Viewer and an affected version are present.

  2. 2
    Prioritize

    Combine exploitation signals with asset exposure and business criticality.

  3. 3
    Remediate

    Follow the vendor advisory or supported update path and preserve rollback options.

  4. 4
    Verify

    Recheck the version, service health, access paths, and relevant logs.

Technical data

CVSS vector
CVSS:4.0/AV:N/AC:L/AT:P/PR:H/UI:A/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
CWE
CWE-506
KEV added
2024.05.29
Ransomware use
미확인
CVE-2024-4978 — Justice AV Solutions Viewer | SECUFOCUS NOW